Work

Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia

Year: 2024

Type: article

Study design: Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2024.07.160

Authors: J.Y.C. Wong, A.M. Monzr, A. Salhotra, S.V. Dandapani, Y. Wang, J. Palmer, C. Han, A. Liu, E.H. Radany, I. Aldoss, H. Ali, L. Farol, F. Sahebi, R. Spielberger, G. Marcucci, R. Nakamura, E. Smith, S.K. Hui, S.J. Forman, A. Stein

Institution: City Of Hope National Medical Center

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402906123

FWCI: 0.534

Cites:

Cited by: 2

Related to: 10